NCT07381621 Perineural Dextrose Versus Local Anesthetic Injections in Knee Osteoarthritis
| NCT ID | NCT07381621 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ankara Training and Research Hospital |
| Condition | Knee Osteoarthritis |
| Study Type | OBSERVATIONAL |
| Enrollment | 86 participants |
| Start Date | 2026-02-02 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 86 participants in total. It began in 2026-02-02 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective observational study aims to compare the clinical effectiveness of perineural 5% dextrose injections and perineural local anesthetic injections in patients with symptomatic knee osteoarthritis. Adult patients receiving routine perineural injection therapy will be followed for six months. Pain intensity and functional outcomes will be assessed at baseline and at 1, 3, and 6 months after treatment using validated clinical assessment tools.
Eligibility Criteria
Inclusion Criteria: * Symptomatic knee osteoarthritis * Clinical/radiological diagnosis * Knee pain ≥ 3 months * Written informed consent Exclusion Criteria: * Prior knee surgery * Recent intra-articular injection * Inflammatory rheumatic disease * Severe systemic or neurological disease * Pregnancy or breastfeeding
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07381621 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 65 Years, studying Knee Osteoarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07381621 currently recruiting?
Yes, NCT07381621 is actively recruiting participants. Contact the research team at nadide.koca@gmail.com for enrollment information.
Where is the NCT07381621 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye), Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07381621 clinical trial?
NCT07381621 is sponsored by Ankara Training and Research Hospital. The trial plans to enroll 86 participants.